CN101732395A - 一种具有免疫调节作用的药物或保健食品组合物及其制备方法和用途 - Google Patents
一种具有免疫调节作用的药物或保健食品组合物及其制备方法和用途 Download PDFInfo
- Publication number
- CN101732395A CN101732395A CN200910263555A CN200910263555A CN101732395A CN 101732395 A CN101732395 A CN 101732395A CN 200910263555 A CN200910263555 A CN 200910263555A CN 200910263555 A CN200910263555 A CN 200910263555A CN 101732395 A CN101732395 A CN 101732395A
- Authority
- CN
- China
- Prior art keywords
- extract
- echinacea
- ganoderma
- compositions
- radix rhodiolae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 99
- 239000003814 drug Substances 0.000 title claims abstract description 47
- 238000002360 preparation method Methods 0.000 title claims abstract description 42
- 235000013305 food Nutrition 0.000 title claims abstract description 7
- 229940079593 drug Drugs 0.000 title abstract description 7
- 230000036039 immunity Effects 0.000 title abstract description 6
- 230000001105 regulatory effect Effects 0.000 title abstract description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 50
- 235000014134 echinacea Nutrition 0.000 claims abstract description 47
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 25
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 25
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 25
- 239000011718 vitamin C Substances 0.000 claims abstract description 25
- 230000000694 effects Effects 0.000 claims abstract description 21
- 206010021143 Hypoxia Diseases 0.000 claims abstract description 5
- 239000000284 extract Substances 0.000 claims description 77
- 241000222336 Ganoderma Species 0.000 claims description 55
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- 235000020694 echinacea extract Nutrition 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 239000012567 medical material Substances 0.000 claims description 21
- 235000013402 health food Nutrition 0.000 claims description 15
- 230000007365 immunoregulation Effects 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 7
- YDDGKXBLOXEEMN-IABMMNSOSA-L Chicoric acid Natural products C1=C(O)C(O)=CC=C1\C=C\C(=O)O[C@@H](C([O-])=O)[C@H](C([O-])=O)OC(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-IABMMNSOSA-L 0.000 claims description 6
- YDDGKXBLOXEEMN-UHFFFAOYSA-N Di-E-caffeoyl-meso-tartaric acid Natural products C=1C=C(O)C(O)=CC=1C=CC(=O)OC(C(O)=O)C(C(=O)O)OC(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-UHFFFAOYSA-N 0.000 claims description 6
- YDDGKXBLOXEEMN-IABMMNSOSA-N chicoric acid Chemical compound O([C@@H](C(=O)O)[C@@H](OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-IABMMNSOSA-N 0.000 claims description 6
- 229930016920 cichoric acid Natural products 0.000 claims description 6
- YDDGKXBLOXEEMN-PMACEKPBSA-N dicaffeoyl-D-tartaric acid Natural products O([C@H](C(=O)O)[C@H](OC(=O)C=CC=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-PMACEKPBSA-N 0.000 claims description 6
- YDDGKXBLOXEEMN-WOJBJXKFSA-N dicaffeoyl-L-tartaric acid Natural products O([C@@H](C(=O)O)[C@@H](OC(=O)C=CC=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-WOJBJXKFSA-N 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 5
- 206010002660 Anoxia Diseases 0.000 claims description 4
- 241000976983 Anoxia Species 0.000 claims description 4
- 230000007953 anoxia Effects 0.000 claims description 4
- 230000002402 anti-lipaemic effect Effects 0.000 claims description 4
- 230000003064 anti-oxidating effect Effects 0.000 claims description 4
- 230000000295 complement effect Effects 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 241000258180 Echinacea <Echinodermata> Species 0.000 claims 5
- 244000133098 Echinacea angustifolia Species 0.000 abstract description 41
- 230000006870 function Effects 0.000 abstract description 9
- 240000008397 Ganoderma lucidum Species 0.000 abstract description 2
- 235000001637 Ganoderma lucidum Nutrition 0.000 abstract description 2
- 244000042430 Rhodiola rosea Species 0.000 abstract description 2
- 235000003713 Rhodiola rosea Nutrition 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 abstract description 2
- 239000008280 blood Substances 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 27
- 229960004397 cyclophosphamide Drugs 0.000 description 27
- 239000002904 solvent Substances 0.000 description 16
- 238000001694 spray drying Methods 0.000 description 16
- 230000037396 body weight Effects 0.000 description 14
- 241000699670 Mus sp. Species 0.000 description 13
- 239000009636 Huang Qi Substances 0.000 description 12
- 230000000242 pagocytic effect Effects 0.000 description 12
- 210000000952 spleen Anatomy 0.000 description 12
- 241000699666 Mus <mouse, genus> Species 0.000 description 11
- 210000001541 thymus gland Anatomy 0.000 description 11
- 210000000056 organ Anatomy 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 239000008194 pharmaceutical composition Substances 0.000 description 7
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 6
- 206010061598 Immunodeficiency Diseases 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 230000036737 immune function Effects 0.000 description 6
- 241000723353 Chrysanthemum Species 0.000 description 5
- 235000007516 Chrysanthemum Nutrition 0.000 description 5
- 238000012449 Kunming mouse Methods 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 241001061264 Astragalus Species 0.000 description 4
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 description 4
- 235000006533 astragalus Nutrition 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 150000003797 alkaloid derivatives Chemical class 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 230000002519 immonomodulatory effect Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 239000007928 intraperitoneal injection Substances 0.000 description 3
- 230000000622 irritating effect Effects 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- 240000004530 Echinacea purpurea Species 0.000 description 2
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- ILRCGYURZSFMEG-RKQHYHRCSA-N Salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RKQHYHRCSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 239000000890 drug combination Substances 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- 240000006409 Acacia auriculiformis Species 0.000 description 1
- 208000002381 Brain Hypoxia Diseases 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000220284 Crassulaceae Species 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- 206010013183 Dislocation of vertebra Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010061998 Hepatic lesion Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241001579678 Panthea coenobita Species 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241001165494 Rhodiola Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229930191701 arteannuin Natural products 0.000 description 1
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 description 1
- 229960004191 artemisinin Drugs 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229930182483 coumarin glycoside Natural products 0.000 description 1
- 150000008140 coumarin glycosides Chemical class 0.000 description 1
- 229940084983 cyclophosphamide 50 mg Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000037451 immune surveillance Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000002864 mononuclear phagocyte Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000005426 pharmaceutical component Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- -1 polysaccharide polyol Chemical class 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 剂量(g/kg) | 动物数(n) | 胸腺指数(mg/g) | 脾指数(mg/g) |
正常对照 | 12 | 3.05±1.04* | 5.22±1.18** | |
CY模型对照 | 12 | 1.85±1.02 | 3.42±1.82 | |
CY+组合物A | 0.224 | 12 | 3.35±1.08** | 5.35±1.45* |
CY+组合物B | 0.160 | 12 | 3.00±1.14* | 4.99±1.07* |
CY+组合物C | 0.290 | 12 | 2.57±1.43 | 3.85±1.16 |
CY+组合物D | 0.350 | 12 | 2.99±1.06* | 5.04±1.08* |
组别 | 剂量(g/kg) | 胸腺指数(mg/g) | 脾指数(mg/g) |
正常对照 | 3.12±1.30** | 5.45±1.23*** | |
CY模型对照 | 1.45±0.75 | 2.62±1.07 | |
CY+组合物A小 | 0.112 | 2.50±0.96* | 4.45±1.88* |
CY+组合物A中 | 0.224 | 3.24±1.11** | 5.29±1.31** |
CY+组合物A大 | 0.448 | 2.35±0.85* | 3.65±0.90* |
CY+紫锥菊 | 0.133 | 2.60±1.23* | 3.94±1.03* |
CY+组合物D | 0.350 | 2.56±1.00* | 4.38±1.32** |
组别 | 剂量(g/kg) | 吞噬指数(k) | 校正吞噬指数(α) |
正常对照 | 0.082±0.029*** | 6.301±0.905*** | |
CY模型对照 | 0.044±0.011 | 3.508±1.202 | |
CY+组合物A小 | 0.112 | 0.070±0.019** | 5.493±1.517** |
CY+组合物A中 | 0.224 | 0.085±0.025*** | 6.723±1.103*** |
CY+组合物A大 | 0.448 | 0.066±0.022* | 4.904±1.394* |
CY+紫锥菊 | 0.133 | 0.074±0.022** | 5.075±1.067* |
CY+组合物D | 0.350 | 0.077±0.027** | 5.269±0.935** |
组别 | 剂量(g/kg) | 动物数(n) | 耳肿胀程度(mg) |
正常对照 | 10 | 3.15±0.71 | |
CY+组合物A小 | 0.112 | 11 | 4.85±1.71* |
CY+组合物A中 | 0.224 | 11 | 5.60±2.53** |
CY+组合物A大 | 0.448 | 11 | 4.35±1.52* |
CY+紫锥菊 | 0.133 | 11 | 4.77±2.06* |
CY+组合物D | 0.350 | 11 | 4.06±0.96* |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102635554A CN101732395B (zh) | 2009-12-24 | 2009-12-24 | 一种具有免疫调节作用的药物或保健食品组合物及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102635554A CN101732395B (zh) | 2009-12-24 | 2009-12-24 | 一种具有免疫调节作用的药物或保健食品组合物及其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101732395A true CN101732395A (zh) | 2010-06-16 |
CN101732395B CN101732395B (zh) | 2012-05-02 |
Family
ID=42456763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009102635554A Expired - Fee Related CN101732395B (zh) | 2009-12-24 | 2009-12-24 | 一种具有免疫调节作用的药物或保健食品组合物及其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101732395B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102499413A (zh) * | 2011-11-03 | 2012-06-20 | 南昌大学 | 一种康复养生饮料及制备方法 |
CN104523795A (zh) * | 2014-12-19 | 2015-04-22 | 吉林天药本草堂制药有限公司 | 鹿茸糖肽组合物在制备耐缺氧药品及保健食品中的应用 |
CN104814373A (zh) * | 2015-05-19 | 2015-08-05 | 河北金木药业集团有限公司 | 一种含菊苣的组合物、微丸及其制备方法 |
CN105267431A (zh) * | 2015-09-30 | 2016-01-27 | 李文 | 一种具有即饮特点的,有降血脂作用的中药保健品组合物 |
CN108013450A (zh) * | 2017-12-01 | 2018-05-11 | 绵阳正耀久生物科技有限公司 | 一种具有提高免疫功能的保健品 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101433630A (zh) * | 2007-11-16 | 2009-05-20 | 北京因科瑞斯医药科技有限公司 | 一种提高免疫力、抗辐射的组合物及其制备方法 |
-
2009
- 2009-12-24 CN CN2009102635554A patent/CN101732395B/zh not_active Expired - Fee Related
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102499413A (zh) * | 2011-11-03 | 2012-06-20 | 南昌大学 | 一种康复养生饮料及制备方法 |
CN104523795A (zh) * | 2014-12-19 | 2015-04-22 | 吉林天药本草堂制药有限公司 | 鹿茸糖肽组合物在制备耐缺氧药品及保健食品中的应用 |
CN104814373A (zh) * | 2015-05-19 | 2015-08-05 | 河北金木药业集团有限公司 | 一种含菊苣的组合物、微丸及其制备方法 |
CN105267431A (zh) * | 2015-09-30 | 2016-01-27 | 李文 | 一种具有即饮特点的,有降血脂作用的中药保健品组合物 |
CN108013450A (zh) * | 2017-12-01 | 2018-05-11 | 绵阳正耀久生物科技有限公司 | 一种具有提高免疫功能的保健品 |
Also Published As
Publication number | Publication date |
---|---|
CN101732395B (zh) | 2012-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101513437B (zh) | 一种抗疲劳中药组合物及其制备方法 | |
CN103719498B (zh) | 一种提高免疫力的黄精保健茶及其制备方法 | |
CN101804165B (zh) | 一种清肾毒,强健五脏六腑,增强体质延缓衰老的制剂及其制备方法 | |
CN102845745A (zh) | 一种铁皮石斛保健品 | |
CN102293927B (zh) | 具有抗疲劳和抗氧化功能的复方中药制剂及其制备方法 | |
CN101732395B (zh) | 一种具有免疫调节作用的药物或保健食品组合物及其制备方法和用途 | |
CN1452875A (zh) | 一种以红景天、灵芝为主料的保健茶及其制备方法 | |
CN102114102B (zh) | 一种具有保肝利胆作用的中药提取物混合制剂及其应用 | |
CN107006856A (zh) | 一种增强耐力、提高抗缺氧耐受力营养剂及其制备方法 | |
CN102784366B (zh) | 一种具有醒酒保肝作用的药物组合物 | |
CN102552527B (zh) | 治疗糖尿病并发症及降糖的中药组合物及其制备方法 | |
CN106581166A (zh) | 一种具有抗疲劳功效的食品、保健品或药物组合物 | |
CN106215118A (zh) | 抗肿瘤的保健制剂及其制备方法 | |
CN101301427A (zh) | 一种药物组合物及其制备方法和用途 | |
CN105831751B (zh) | 补气健脑的中药保健组合物、制备方法及其使用方法 | |
CN105168566A (zh) | 一种保健组合物 | |
CN104274568A (zh) | 一种抗疲劳复方制剂及其制备方法 | |
CN1611232A (zh) | 一种以抗疲劳、抗辐射、抗忧郁为主功效的药物组合物及其制法 | |
CN100398115C (zh) | 治疗酒精性肝损伤的药物及其制备方法 | |
CN106309736A (zh) | 抗疲劳中药组合物及其制备方法和用途 | |
CN105477465A (zh) | 一种具有保护肝功能的中药制剂及其制备工艺 | |
CN105232958A (zh) | 一种用于制备治疗重症肌无力的药物的中药组合物 | |
CN111759878A (zh) | 一种降血糖的中药组合物及其制备方法 | |
CN110522798A (zh) | 一种主治冠心病的复方制剂及其制备方法 | |
CN114470085A (zh) | 一种提升血氧饱和度的草本雾化组合物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20100616 Assignee: CHENGDU HUAYU PHARMACEUTICAL CO.,LTD. Assignor: Chengdu BaoXi'ang Health Technology Co.,Ltd. Contract record no.: 2012510000086 Denomination of invention: Medicine or health-care food composition with function of regulating immunity, preparation method and application thereof Granted publication date: 20120502 License type: Exclusive License Record date: 20120822 |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120502 |